Boehringer and AnGes sign manufacturing agreement for HGF gene therapy product
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
Brian Foard will lead the Specialty Care GBU ad interim, effective immediately.
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
There are certain foods can influence blood pressure, triglycerides, cholesterol levels and inflammation, all of which are risk factors for heart disease.
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
Sputnik Light can become a major booster for those vaccinated with inactivated Chinese Covid-19 vaccines globally after China has officially recommended mix & match approach with adenoviral vector-based vaccines as boosters
FGFR alterations are prevalent in early-stage bladder cancer, appearing in roughly 70% of intermediate-risk and 40% of high-risk NMIBC tumors
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
Subscribe To Our Newsletter & Stay Updated